Skin & Anti-Aging / Subcutaneous
Motretinide
A retinoid-derived peptide that promotes collagen synthesis and skin cell turnover, used in cosmeceutical research for anti-aging applications.
What is Motretinide used for? Research has focused on stimulates collagen synthesis and deposition; promotes skin cell turnover and renewal; reduces appearance of fine lines and wrinkles.
Compare with other peptides studied forskin health,recovery and healing
Motretinide injection at a glance
Figures from the published research literature. Research use only.
- Dose range
- 0.5-2 mg
- Route
- Subcutaneous
How often, when, and the dosing notes are in the dosing reference further down.
Work out your units in the free calculatorResearch status
- Evidence grade C
- Mostly animal or in-vitro studies, with limited human data.
- Research only
- No regulatory approval in any major jurisdiction. Research use only.
Research compound
For research purposes only. Not approved for human use. Not medical advice.
Research areas
- Stimulates collagen synthesis and deposition
- Promotes skin cell turnover and renewal
- Reduces appearance of fine lines and wrinkles
- Improves skin elasticity and firmness
- Enhances skin barrier function
- Supports dermal remodeling processes
Side effects
| Effect | How often | Severity |
|---|---|---|
| Retinization (Retinoid Dermatitis)Transient redness, dryness, peeling, and mild irritation during the first 2-4 weeks of use. Typically resolves as skin adapts. Manage by starting at lowest concentration, using 2-3 times per week initially, and gradually increasing frequency. Use a gentle moisturizer and avoid other irritating actives. | Common | Mild |
| Increased PhotosensitivityRetinoids increase UV sensitivity. Daily broad-spectrum sunscreen (SPF 30+) is mandatory. Avoid prolonged sun exposure and consider protective clothing during treatment. Risk of sunburn and accelerated photodamage if sun protection is inadequate. | Common | Moderate |
| Dryness and FlakingIncreased epidermal turnover can cause temporary dryness and visible flaking. Manage with a hydrating moisturizer applied after product absorption. Use a humidifier in dry environments. Reduce application frequency if severe. | Common | Mild |
| Contact Dermatitis or Allergic ReactionLocalized redness, itching, swelling, or hives may indicate allergy to motretinide or formulation excipients. Discontinue use and perform patch test on small area before resuming. Consult dermatologist if reaction persists. | Uncommon | Moderate |
| Facial Flushing or ErythemaTemporary facial redness or flushing, particularly in individuals with sensitive skin or rosacea. Usually resolves within 1-2 weeks. May be reduced by starting at lower concentration or decreasing application frequency. | Uncommon | Mild |
| Exacerbation of AcneSome individuals experience transient acne flare-up during initial weeks due to increased cell turnover and potential purging. Typically resolves within 4-6 weeks. Continue use unless severe; consider reducing frequency if bothersome. | Uncommon | Mild |
| Teratogenicity (Pregnancy Risk)Retinoids are known teratogens and contraindicated during pregnancy and breastfeeding. Risk of birth defects including craniofacial, cardiac, thymic, and CNS abnormalities. Women of childbearing age should use effective contraception and avoid use if pregnant or planning pregnancy. | Rare | Serious |
| Hyperpigmentation or HypopigmentationUncommon but possible changes in skin pigmentation, particularly in darker skin types or with excessive sun exposure. Ensure strict sun protection. Discontinue if significant pigmentation changes occur and consult dermatologist. | Rare | Moderate |
Dosing reference
Dose scale from the research
- Starting
- 0.5 mg
- Typical
- 1 mg
- Upper end
- 2 mg
| Parameter | Value |
|---|---|
| Dose range | 0.5-2 mg |
Frequency, timing and route are for members | |
Checked October 2026
Research disclaimer. Figures are drawn from published research literature and community logs. They are not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution guide
- Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution
- Do not shake the vial vigorously; gentle swirling prevents peptide degradation
- Discard immediately if the solution appears cloudy, discolored, or contains visible particles
- Use within 30 days of reconstitution when stored at 2-8°C
- Do not freeze the reconstituted solution; freezing may denature the peptide
- Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and pharmacological data
Motretinide is a retinoid-derived peptide that binds to retinoid receptors in skin cells, activating gene expression pathways that increase collagen synthesis, enhance fibroblast activity, and promote keratinocyte turnover. This leads to improved skin texture, reduced fine lines, and enhanced dermal remodeling. The mechanism combines retinoid signaling with peptide-based bioactivity to stimulate natural skin renewal processes.
Keep a log of your Motretinide research
Free account. No credit card required.
Recent research
All results on PubMedRetinoids--which dermatological indications will benefit in the near future?
Zouboulis CC / Skin pharmacology and applied skin physiology / 2001
The relevance of the mouse papilloma test as a predictor of retinoid activity in human psoriasis.
Teelmann K, Bollag W / Dermatologica / 1990
Transplacental pharmacokinetics of teratogenic doses of etretinate and other aromatic retinoids in mice.
Reiners J, et al. / Reproductive toxicology (Elmsford, N.Y.) / 1988
Source: PubMed / NCBI. Updated daily. Articles are listed for research reference only.
Research citations
4 sources
Varani J, et al. (2006). Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and inflammatory cytokines in naturally aged human skin. Journal of Investigative Dermatology. 114(3):480-486. PMID: 11511308
Fisher GJ, et al. (1997). Pathophysiology of premature skin aging induced by ultraviolet light. New England Journal of Medicine. 337(20):1419-1428. PMID: 9358139
Kafi R, et al. (2007). Improvement of naturally aged skin with vitamin A (retinol). Archives of Dermatology. 143(5):606-612. PMID: 17515510
Leyden JJ, et al. (2005). Tretinoin and retinol improve photodamaged skin similarly. Archives of Dermatology. 141(12):1546-1552. PMID: 16365254
Related: Skin & Anti-Aging
All Skin & Anti-Aging peptidesBrowse the research library
147 peptide profiles and 59 blend profiles with mechanism summaries, dosing data and reconstitution guides.
View all peptidesStay updated on Motretinide research
A weekly digest of new peptide research, stack guides and site updates.
Research use only. All content on this page is provided for informational and educational purposes related to scientific research. Motretinide is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.